Series | No. | Sex | Age | FNA results | Overall malignancy rate | Statistical analysis | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | F | Benign | Malign | Suspicious | Insufficient | Sen | Sp | Acc | PPV | NPV | ||||
Arda et al | 46 | 9 (19%) | 37 (81%) | 9 | 38 (82%) | 3 (7%) | 3 (7%) | 2 (4%) | 7% | 100% | 95% | 95% | 67% | 100% |
Al-Shaikhet al 17 | 41 | 35 (85%) | 6 (15%) | 13 | 30 (73%) | 2 (5%) | 6 (15%) | 3 (7%) | 5% | 87% | 100% | 87% | 29% | 100% |
Khuranaet al 16 | 57 | 11 (19%) | 46 (81%) | 17 | 36 (63%) | 7 (12%) | 14 (25%) | 0 | 25% | 93% | 81% | 84% | 62% | 97% |
Lugo-Vicente et al 15 | 24 | 4 (%17) | 20 (83%) | 15 | 11 (61%) | 2 (11%) | 2 (11%) | 3 (17%) | 21% | 60% | 90% | 80% | 75% | 81% |
Degnanet al 14 | 18 | 4 (22%) | 14 (78%) | 14 | 7 (41%) | 2 (12%) | 7 (41%) | 1 (6%) | 33% | 73% | 80% | 75% | 89% | 57% |
Raabet al 13 | 57 | 8 (14%) | 49 (86%) | 13 | 51 (77%) | 4 (6%) | 8 (12%) | 3 (5%) | 18% | 80% | 86% | 85% | 36% | 98% |
No., number of patients; M, male; F, female; Sen, sensitivity; Sp, specificity; Acc, accuracy; PPV, positive predictive value; NPV, negative predictive value.